4
Changes in Ownership
Allogene Therapeutics, Inc. Filed Acc 0001209191-19-041955
President and CEO acquired 16,542 shares (other)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Chang David D President and CEO | 2019-06-18 | Other acquisition | +10,154 | 1,135,498 | I: show line 1 in the form | ||
| Chang David D President and CEO | 2019-07-10 | Other acquisition | +6,388 | 2,176,687 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…